Clinical Trial Details
EORTC-30911
Back to Clinical Trials Database
Phase III trial of intravesical instillation of Epirubicin, BCG or BCG + INH in intermediate and high risk pTa-pT1 papillary carcinoma of the urinary bladder
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 23-Dec-1991 Date Step1 close: 03-Mar-1997 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 570 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
